Showing 491-500 of 1066 results for "".
The Science Behind FcRn Antagonists: A Deep Dive Into Their Mechanism of Action
https://practicalneurology.com/programs/cme/the-science-behind-fcrn-antagonists-a-deep-dive-into-their-mechanism-of-action/32241/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Case Report: Noninvasive Intracranial Pressure Monitoring
https://practicalneurology.com/diseases-diagnoses/imaging-testing/case-report-noninvasive-intracranial-pressure-monitoring/31804/Global cerebral edema secondary to acute hyponatremia illustrates the use of noninvasive intracranial pressure monitoring.Incorporating FcRn Inhibitors Into Clinical Practice in Chronic Inflammatory Demyelinating Polyneuropathy
https://practicalneurology.com/programs/cme/incorporating-fcrn-inhibitors-into-clinical-practice-in-chronic-inflammatory-demyelinating-polyneuropathy/27135/Tune in to learn more about how to incorporate FcRn inhibitors into clinical practice for inflammatory demyelinating polyneuropathy (CIDP).Multiple Sclerosis in People Over Age 55
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-in-people-over-age-55/31759/The average age of people with MS is increasing, but knowledge of the disease in people over age 55 remains sparse.Special Report: Neuro-oncology
https://practicalneurology.com/diseases-diagnoses/imaging-testing/special-report-neuro-oncology/31582/Part 1. Epidemiology, clinical evaluation, and diagnosisAntisense Oligonucleotide Therapies
https://practicalneurology.com/diseases-diagnoses/movement-disorders/antisense-oligonucleotide-therapies/31573/Antisense oligonucleotides are a promising new therapeutic class being studied for the treatment of movement disorders.Case Report: Cerebral Aneurysm Rerupture
https://practicalneurology.com/diseases-diagnoses/stroke/case-report-cerebral-aneurysm-rerupture/31817/Antifibrinolytic therapy may induce cerebral aneurysmal thrombosis that can obscure unstable aneurysms, delaying diagnosis and treatment.Headache Disorders: Lifestyle & Behavioral Management
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-disorders-lifestyle-behavioral-management/31771/Nonmedication treatment may address triggers and symptoms of headache disorders.Balancing Risk and Benefit: Traditional MG Treatments and Medications to Avoid
https://practicalneurology.com/programs/cme/balancing-risk-and-benefit-traditional-mg-treatments-and-medications-to-avoid/32240/While traditional gMG treatments bring many debilitating side effects, a more targeted approach focusing on the FcRn complex has shown great promise.Pediatric Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/pediatric-traumatic-brain-injury/31985/Assessment, acute care treatment, and rehabilitation and recovery